We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Inquiry by US regulator focuses on whether manufacturers colluded in relation to programme for low-income families
Shortage following Abbott safety scandal draws scrutiny of sector dominated by just two companies
Crisis points to the vulnerability of a supply chain dominated by too few producers
A fresh push on fast and reliable Covid diagnostics is needed to supplement the vaccine effect
Investors are better off putting their money on test makers rather than test processors
The $5 kit can confirm in as little as 15 minutes whether someone has Covid-19
Consumers and doctors eager to understand who has immunity face uncertainty over testing and reliability
And trials of 20-minute swab test to determine coronavirus infection will start next week
David Crow on the complications — and consequences — of testing for coronavirus immunity
Public Health England gives green light to second diagnostic kit to detect past infection and potential immunity
‘Early data’ show analysis might be returning false negative results in almost half of cases
US healthcare groups bring hope in race to fight coronavirus pandemic
US medical device makers end protracted legal dispute with deal at reduced price
There is an awkward dance between signing a deal and closing it
Despite a series of good bets, the hedge fund’s short call on devices maker is challenged
Hedge fund uses alleged cyber flaws to a stock falling.put pressure on St Jude Medical
Ian Read says case for drugmaker’s break-up has become ‘more complicated’ in recent months
Merger of US groups will create $18bn clinical trials and data specialist
Cash-rich corporates are in the vanguard
Abbott, AbbVie and Sanofi announce separate purchases, taking 2016 transactions to $121bn
Acquisition of medical devices group resumes pharma merger spree
UK Edition
